Delayed
Hong Kong S.E.
01:24:55 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
3.35
HKD
|
0.00%
|
|
+3.72%
|
+12.79%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,871
|
6,509
|
5,362
|
2,450
|
2,764
|
-
|
-
|
Enterprise Value (EV)
1 |
2,871
|
6,509
|
5,362
|
2,450
|
2,764
|
2,764
|
2,764
|
P/E ratio
|
5.71
x
|
-
|
4.84
x
|
6.21
x
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
7.92%
|
13%
|
15.1%
|
Capitalization / Revenue
|
-
|
1,255,172
x
|
-
|
604,913
x
|
-
|
-
|
-
|
EV / Revenue
|
-
|
1,255,172
x
|
-
|
604,913
x
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
3,987,106
x
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
1.17
x
|
-
|
-
|
0.45
x
|
0.4
x
|
0.36
x
|
Nbr of stocks (in thousands)
|
825,000
|
825,000
|
825,000
|
825,000
|
825,000
|
-
|
-
|
Reference price
2 |
3.480
|
7.890
|
6.500
|
2.970
|
3.350
|
3.350
|
3.350
|
Announcement Date
|
3/2/21
|
3/7/22
|
3/1/23
|
3/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
|
-
|
5,186
|
-
|
4,051
|
-
|
-
|
-
|
EBITDA
|
-
|
1,633
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
1,576
|
-
|
539.6
|
-
|
-
|
-
|
Operating Margin
|
-
|
30.38%
|
-
|
13.32%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
493.9
|
-
|
-
|
-
|
Net income
1 |
502.6
|
-
|
1,157
|
400.7
|
555.7
|
915
|
1,059
|
Net margin
|
-
|
-
|
-
|
9.89%
|
-
|
-
|
-
|
EPS
|
0.6090
|
-
|
1.344
|
0.4780
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
0.2652
|
0.4366
|
0.5056
|
Announcement Date
|
3/2/21
|
3/7/22
|
3/1/23
|
3/8/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
25.7%
|
-
|
-
|
9.26%
|
14%
|
14.6%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
6.760
|
-
|
-
|
7.510
|
8.360
|
9.210
|
Cash Flow per Share
|
-
|
1.730
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
673
|
-
|
-
|
823
|
823
|
-
|
Capex / Sales
|
-
|
12.97%
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/2/21
|
3/7/22
|
3/1/23
|
3/8/24
|
-
|
-
|
-
|
Last Close Price
3.35
HKD Average target price
4.1
HKD Spread / Average Target +22.39% Consensus |
1st Jan change
|
Capi.
|
---|
| +12.79% | 353M | | +1.20% | 67.05B | | +44.29% | 40.4B | | +15.99% | 38.64B | | +4.67% | 32.41B | | +6.59% | 19.17B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B | | -14.74% | 13.81B |
Other Commodity Chemicals
|